Studies with Drosophila indicated that during eye development, Spry inhibits signaling downstream of the epidermal growth factor receptor (EGFR) and upstream of rous sarcoma (Ras) [1] but functions at the level of rapidly accelerated fibrosarcoma (Raf) during wing and ovary development [23]. This evidence concerns the gene EGFR and fibrosarcoma.